RedHill Biopharma Ltd.RDHLNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank7
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 3Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -54.99% |
| 2023 | -51.53% |
| 2022 | -75.32% |
| 2021 | 78.87% |
| 2020 | -5.33% |
| 2019 | -29.94% |
| 2018 | -24.59% |
| 2017 | 30.62% |
| 2016 | 42.03% |
| 2015 | 39.93% |